| Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
| c.61T>A | p.Ser21Thr | Heterozygous | Mutation |
| wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
| TCT | Ser | ACT | Thr | T->A | Tv |
| Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
| L1-THAP dom. | Yes, coding strand | No |
| At the mRNA level | On restriction map |
| NA | New restriction site(s): Mae III Lost restriction site(s): none |
| Conservation (0-1) | SIFT (0-1) | UMD-predictor (0-100) |
|---|---|---|
| 0.71 | 0.00 (pathogenous) | 47 (Polymorphism) |
| Sample ID | Patient ID | Family ID | Patient status | Gender | Transmission | Geographic origin |
| USA01NYO F0008 I0001 | C0008 | 9 | Proband | Unknown | Familial | U.S.A. |
| Phenotypic group | Disease |
| NA | Unknown |
Genealogic tree |
| Symptom |
| No clinical data available |
| Mutation abolishs binding of THAP1 to TOR1A, see Gavarini et al. Annals of Neurology, 2010. |
| Reference ID | PubMed ID | Reference |
| 2 | 19345148 | Bressman SB, Raymond D, Fuchs T, Heiman GA, Ozelius LJ, Saunders-Pullman R. Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study. Lancet Neurol. 2009 May;8(5):441-6. |